Previous Close |
---|
25,064.36 |
5 Day |
|
1 Month |
|
3 Month |
|
YTD |
|
1 Year |
|
Short-dated Treasury yields rise on Tuesday after Federal Reserve Chairman Jerome Powell, as expected, highlighted the need for a gradual pace of rate increases in testimony on Capitol Hill.
U.S. stock on Tuesday closed firmly higher and the technology-heavy Nasdaq notched a fresh record after Federal Reserve Chairman Jerome Powell indicated that the U.S. central bank would continue raising benchmark rates due the the health of the economy but would execute its monetary-policy strategy at a prudent pace. The Dow Jones Industrial Average closed up 0.2% at 25,119 (on a preliminary basis), marking its fourth straight positive finish in succession. The blue-benchmark's gains were buoyed by a rally in component Johnson & Johnson , which reported second-quarter earnings and revenue that were better than expected. Shares of the consumer-goods company gained 3.5% and contributed the lion's share of the equity index's Tuesday advance. The S&P 500 index closed up 0.4% at 2,809, while the Nasdaq Composite Index booked an all-time closing high, with a gain of 0.6% at 7,855. Providing testimony in front of the Senate Banking Committee, Powell said the "best way forward is to keep gradually raising the federal-funds rate for now." He will appear before a House committee on Wednesday. Meanwhile, economic reports supported the upbeat mood amid second-quarter corporate results that have mostly come out better than expected. Industrial production rose 0.6% in June to more than offset a similarly sized decline in May, the Federal Reserve said Tuesday. That was a tick above the MarketWatch forecast.
Dow marks fourth straight finish in the green
Nasdaq closes up 0.6%
Dow closes up 0.2%; S&P 500 finishes with a gain of 0.4%
U.S. stocks end solidly higher on the heels of Day 1 of Powell testimony
Nasdaq books fresh record close
Bitcoin prices surged more than 10% Tuesday, taking the No. 1 digital currency back above $7,000 for the first time in five weeks and on track to record its biggest daily gain since April 12. In doing so, bitcoin traded above its 50-day moving average, a closely watched momentum indicator. The rally for bitcoin has been aided by four consecutive winning days, which if gains hold also would represent its longest stretch since April. A single bitcoin last changed hands at $7,371.87, up 10.7% since Monday 5 p.m. on the Kraken crypto exchange. By comparison the Dow Jones Industrial Average has gained 0.3%, the S&P 500 is up 0.5% and the Nasdaq Composite Index is higher by 0.6%.
President Donald Trump on Tuesday told reporters he accepts the assessment of U.S. intelligence that Russia meddled in the U.S. election. He added his administration would move aggressively to fight any efforts to interfere in 2018. On Monday, Trump said at a joint press conference with Vladimir Putin that he found the Russian president's denial "powerful."
Cellectar Biosciences Inc. shares rose 15% in Tuesday trade after the company announced that one patient in a phase 2 trial for its cancer therapy had a major improvement in the amount of tumor material in her body, or an about 94% reduction. The trial, which is studying the therapy in patients with certain B-cell malignancies, intends to enroll about 80 participants total, according to Clinicaltrials.gov, and has an expected completion date of March 2019. The patient, who has a rare type of cancer called Waldenstrom macroglobulinemia, was administered two doses of the therapy, CLR 131, after which she showed the large reduction in tumor burden and complete resolution of four of five targeted tumor masses, the company said. Other symptoms that affected the patient's quality of life also improved, the treating physician, Dr. Sikander Ailawadhi, said. Importantly, the results of one patient may have no bearing on whether the trial is ultimately successful. Cellectar shares have surged 613% over the last three months, compared with a 3.8% rise in the S&P 500 and a 1.1% rise in the Dow Jones Industrial Average .
U.S. stocks turn positive; S&P 500 up 0.1%
Johnson & Johnson shares rose 3.7% in Tuesday morning trade after the company reported second-quarter earnings and revenue beats. Earnings for the latest quarter rose to $3.95 billion, or $1.45 per share, from $3.83 billion, or $1.40 per share in the year-earlier period. Adjusted earnings-per-share were $2.10, above the FactSet consensus of $2.07. Revenue rose to $20.83 billion from $18.84 billion, above the FactSet consensus of $20.39 billion. Pharmaceutical sales beat the consensus, with above-consensus sales for Simponi, Stelara, Prezisa/TMC, Concerta, Invega, Darzalex, Imbruvica and Zytiga, and below-consensus sales of Remicade, Edurant and Xarelto. Sales of medical devices also came in above the consensus. Yet consumer sales came in below consensus, with oral care and women's health sales above consensus, while baby care, oral care, skin care and wound care sales were below consensus. Johnson & Johnson now expects 2018 sales of $80.5 billion to $81.3 billion, reflecting an increase in expected operational growth and offset by an estimated lower favorable impact of currency; the guidance is below the FactSet consensus of $81.4 billion. Johnson & Johnson shares have dropped 0.7% over the last three months, compared with a 3.3% rise in the S&P 500 and a 1.1% rise in the Dow Jones Industrial Average .
Prices for things like gasoline, food and housing are rising faster than U.S. consumers' wages, a potential threat to the U.S. expansion and the stock market.
General Electric Co.’s removal from the Dow Jones Industrial Average this past week was a new low for the struggling industrial giant. But it could also be a sign of brighter days ahead.
Investors are gobbling up the shares of small U.S. companies, a sign of how they're retreating from some overseas markets.
Eighty-six years ago this week, the stock market hit its worst low. Today’s high-flying market looks like a polar opposite. But information is still power.
Shares of small companies are once again climbing to new highs, but that doesn't mean larger companies will follow suit.
U.S. stock funds are on track for a third straight month of outflows as investors grow wary of the aging bull market.
Oakmark Fund's Commentary: The World Cup and Investing
Why Art and Investing Have Much in Common
How to Get the Extra Money to Fuel Your Investments
At the end of the second quarter, T. Rowe Price had assets under management of $1.04 trillion, a marginal rise month-over-month.
U.S. consumer prices rose for the third-consecutive month in June. Last month's price increases brought the CPI's growth from a year earlier to 2.9%, the highest monthly uptick in the last 4 years.
Cobas Funds Commentary: Investing Against the Consensus
Mohamed El-Erian: What the Market Hasn't Realized About Trade War
Royce Funds Commentary: The Economy Looks Normal—Why Don’t the Markets?
Key U.S. | Last | Chg | Chg % |
---|---|---|---|
Dow Jones Industrial Average | |||
NASDAQ Composite Index | |||
S&P 500 Index | |||
Russell 2000 Index | |||
Other U.S. | Last | Chg | Chg % |
Dow Jones Transportation Average | |||
Dow Jones Utility Average Index | |||
Dow Jones U.S. Total Stock Market Index | |||
NASDAQ 100 Index (NASDAQ Calculation) | |||
S&P 400 Mid Cap Index | |||
NYSE Composite Index | |||
Barron's 400 Index | |||
CBOE Volatility Index | |||
Global | Last | Chg | Chg % |
Global Dow Realtime USD | |||
Asia/Pacific | Last | Chg | Chg % |
The Asia Dow Index USD | |||
S&P/ASX 200 Benchmark Index | |||
Shanghai Composite Index | |||
Hang Seng Index | |||
S&P BSE Sensex Index | |||
NIKKEI 225 Index | |||
FTSE Straits Times Index | |||
Europe | Last | Chg | Chg % |
STOXX Europe 50 Index | |||
STOXX Europe 600 Index | |||
CAC 40 Index | |||
DAX | |||
IBEX 35 Index | |||
FTSE 100 Index | |||
Americas | Last | Chg | Chg % |
BOVESPA Index | |||
S&P/TSX Composite Index | |||
IPC Indice de Precios Y Cotizaciones |
Company | Last | Chg | Chg % |
---|---|---|---|
Johnson & Johnson | |||
DowDuPont Inc. | |||
United Technologies Corp. | |||
Coca-Cola Co. | |||
Home Depot Inc. | |||
Microsoft Corp. | |||
VISA Inc. Cl A | |||
Pfizer Inc. | |||
Walgreens Boots Alliance Inc. | |||
Caterpillar Inc. | |||
Procter & Gamble Co. | |||
Walmart Inc. | |||
McDonald's Corp. | |||
3M Co. | |||
Travelers Cos. Inc. | |||
American Express Co. | |||
Apple Inc. | |||
Boeing Co. | |||
Walt Disney Co. | |||
JPMorgan Chase & Co. | |||
Merck & Co. Inc. | |||
Goldman Sachs Group Inc. | |||
Exxon Mobil Corp. | |||
Verizon Communications Inc. | |||
Nike Inc. Cl B | |||
Cisco Systems Inc. | |||
Intel Corp. | |||
Chevron Corp. | |||
International Business Machines Corp. | |||
UnitedHealth Group Inc. |